Abstract
References
1.
Heinemann
L
. Biosimilar insulins . Expert Opin Biol Ther . 2012 ; 12 (8 ): 1009 –16 .
2.
Owens
DR
Landgraf
W
Schmidt
A
Bretzel
RG
Kuhlmann
MK
. The emergence of biosimilar insulin preparations—a cause for concern? . Diabetes Technol Ther . 2012 ; 14 (11 ): 989 –96 .
3.
Heise
T
Bott
S
Tusek
C
Stephan
JA
Kawabata
T
Finco-Kent
D
Liu
C
Krasner
A
. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: A prospective randomized pharmacodynamic study . Diabetes Care . 2005 ; 28 (9 ): 2161 –9 .
4.
Kuhlmann
M
Marre
M
. Lessons learned from biosimilar epoetins and insulins . Br J Diabetes Vasc Dis . 2010 ; 10 (2 ): 90 –7 .